| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T24 |
1-14 |
NNS |
denotes |
coronaviruses |
| T25 |
15-16 |
-LRB- |
denotes |
( |
| T26 |
16-20 |
NNS |
denotes |
CoVs |
| T27 |
20-21 |
-RRB- |
denotes |
) |
| T28 |
22-25 |
VBP |
denotes |
are |
| T29 |
26-34 |
JJ |
denotes |
zoonotic |
| T30 |
35-44 |
NNS |
denotes |
pathogens |
| T31 |
45-49 |
IN |
denotes |
with |
| T32 |
50-54 |
JJ |
denotes |
high |
| T33 |
55-63 |
NN |
denotes |
fatality |
| T34 |
64-69 |
NNS |
denotes |
rates |
| T35 |
70-73 |
CC |
denotes |
and |
| T36 |
74-82 |
JJ |
denotes |
pandemic |
| T37 |
83-92 |
NN |
denotes |
potential |
| T38 |
94-101 |
NN |
denotes |
Vaccine |
| T39 |
102-113 |
NN |
denotes |
development |
| T40 |
114-121 |
VBZ |
denotes |
focuses |
| T41 |
122-124 |
IN |
denotes |
on |
| T42 |
125-128 |
DT |
denotes |
the |
| T43 |
129-138 |
JJ |
denotes |
principal |
| T44 |
139-145 |
NN |
denotes |
target |
| T45 |
146-148 |
IN |
denotes |
of |
| T46 |
149-152 |
DT |
denotes |
the |
| T47 |
153-165 |
VBG |
denotes |
neutralizing |
| T48 |
166-173 |
JJ |
denotes |
humoral |
| T49 |
174-180 |
JJ |
denotes |
immune |
| T50 |
181-189 |
NN |
denotes |
response |
| T51 |
189-190 |
-COMMA- |
denotes |
, |
| T52 |
191-194 |
DT |
denotes |
the |
| T53 |
195-200 |
NN |
denotes |
spike |
| T54 |
201-202 |
-LRB- |
denotes |
( |
| T55 |
202-203 |
NN |
denotes |
S |
| T56 |
203-204 |
-RRB- |
denotes |
) |
| T57 |
205-217 |
NN |
denotes |
glycoprotein |
| R21 |
T28 |
T24 |
arg1Of |
are,coronaviruses |
| R22 |
T24 |
T25 |
arg1Of |
coronaviruses,( |
| R23 |
T26 |
T25 |
arg2Of |
CoVs,( |
| R24 |
T27 |
T25 |
arg3Of |
),( |
| R26 |
T30 |
T28 |
arg2Of |
pathogens,are |
| R27 |
T30 |
T29 |
arg1Of |
pathogens,zoonotic |
| R28 |
T30 |
T31 |
arg1Of |
pathogens,with |
| R29 |
T35 |
T31 |
arg2Of |
and,with |
| R30 |
T34 |
T32 |
arg1Of |
rates,high |
| R31 |
T34 |
T33 |
arg1Of |
rates,fatality |
| R32 |
T34 |
T35 |
arg1Of |
rates,and |
| R33 |
T37 |
T35 |
arg2Of |
potential,and |
| R34 |
T37 |
T36 |
arg1Of |
potential,pandemic |
| R35 |
T39 |
T38 |
arg1Of |
development,Vaccine |
| R36 |
T39 |
T40 |
arg1Of |
development,focuses |
| R37 |
T40 |
T41 |
arg1Of |
focuses,on |
| R38 |
T44 |
T41 |
arg2Of |
target,on |
| R39 |
T44 |
T42 |
arg1Of |
target,the |
| R40 |
T44 |
T43 |
arg1Of |
target,principal |
| R41 |
T44 |
T45 |
arg1Of |
target,of |
| R42 |
T50 |
T45 |
arg2Of |
response,of |
| R43 |
T50 |
T46 |
arg1Of |
response,the |
| R44 |
T50 |
T47 |
arg1Of |
response,neutralizing |
| R45 |
T50 |
T48 |
arg1Of |
response,humoral |
| R46 |
T50 |
T49 |
arg1Of |
response,immune |
| R47 |
T50 |
T51 |
arg1Of |
response,"," |
| R48 |
T57 |
T51 |
arg2Of |
glycoprotein,"," |
| R49 |
T57 |
T52 |
arg1Of |
glycoprotein,the |
| R50 |
T57 |
T53 |
arg1Of |
glycoprotein,spike |
| R51 |
T53 |
T54 |
arg1Of |
spike,( |
| R52 |
T55 |
T54 |
arg2Of |
S,( |
| R53 |
T56 |
T54 |
arg3Of |
),( |
